Scarica l'app Stockscreener
111.25
5.53%
5.83
Pre-mercato:
111.29
0.04
+0.04%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché GH Giù?
Forum
Previsione
Precedente Chiudi:
$105.42
Aprire:
$105.79
Volume 24 ore:
2.82M
Relative Volume:
1.05
Capitalizzazione di mercato:
$14.02B
Reddito:
$692.26M
Utile/perdita netta:
$-512.41M
Rapporto P/E:
-26.24
EPS:
-4.24
Flusso di cassa netto:
$-274.36M
1 W Prestazione:
+15.31%
1M Prestazione:
+54.19%
6M Prestazione:
+192.76%
1 anno Prestazione:
+240.74%
Intervallo 1D:
$104.35
$111.91
Intervallo di 1 settimana:
$94.05
$111.91
Portata 52W:
$29.91
$111.91
Guardant Health Inc Stock (GH) Company Profile
Nome
Guardant Health Inc
Settore
Industria
Telefono
855-698-8887
Indirizzo
3100 HANOVER STREET, PALO ALTO
Confronta GH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GH
Guardant Health Inc
|
111.25 | 13.69B | 692.26M | -512.41M | -274.36M | -4.24 |
|
TMO
Thermo Fisher Scientific Inc
|
586.07 | 220.72B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
226.98 | 160.62B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
752.14 | 57.96B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
153.60 | 42.88B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
228.18 | 38.30B | 15.90B | 1.28B | 2.21B | 7.2842 |
Guardant Health Inc Stock (GH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-25 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2025-09-22 | Ripresa | Wells Fargo | Overweight |
| 2025-04-10 | Iniziato | Mizuho | Outperform |
| 2025-01-23 | Iniziato | Barclays | Overweight |
| 2024-06-28 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-04-24 | Ripresa | Craig Hallum | Buy |
| 2023-12-14 | Iniziato | Guggenheim | Neutral |
| 2023-12-13 | Iniziato | Wolfe Research | Peer Perform |
| 2023-11-13 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2023-09-28 | Iniziato | Bernstein | Outperform |
| 2023-09-27 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-07-05 | Ripresa | JP Morgan | Overweight |
| 2023-05-26 | Aggiornamento | Citigroup | Neutral → Buy |
| 2023-05-05 | Iniziato | UBS | Buy |
| 2023-03-09 | Downgrade | Citigroup | Buy → Neutral |
| 2023-01-05 | Iniziato | Scotiabank | Sector Outperform |
| 2022-11-01 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-10-19 | Iniziato | Craig Hallum | Buy |
| 2022-10-06 | Iniziato | Stephens | Overweight |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-06-03 | Iniziato | Piper Sandler | Overweight |
| 2022-04-28 | Ripresa | BTIG Research | Buy |
| 2022-02-24 | Reiterato | Canaccord Genuity | Buy |
| 2022-02-24 | Reiterato | Citigroup | Buy |
| 2022-02-24 | Reiterato | Cowen | Outperform |
| 2022-02-24 | Reiterato | Morgan Stanley | Overweight |
| 2022-02-24 | Reiterato | SVB Leerink | Outperform |
| 2022-02-24 | Reiterato | Stifel | Buy |
| 2022-02-24 | Reiterato | Wells Fargo | Overweight |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-06-15 | Iniziato | Raymond James | Mkt Perform |
| 2021-06-03 | Iniziato | Goldman | Buy |
| 2021-05-25 | Iniziato | Wells Fargo | Overweight |
| 2021-01-11 | Iniziato | Stifel | Buy |
| 2020-09-09 | Iniziato | Morgan Stanley | Overweight |
| 2020-06-12 | Iniziato | BTIG Research | Buy |
| 2020-02-21 | Iniziato | Guggenheim | Buy |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-08-07 | Reiterato | Canaccord Genuity | Buy |
| 2019-04-16 | Iniziato | Canaccord Genuity | Buy |
| 2019-04-10 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-02-28 | Reiterato | BofA/Merrill | Neutral |
| 2018-10-29 | Iniziato | BofA/Merrill | Neutral |
| 2018-10-29 | Iniziato | JP Morgan | Overweight |
| 2018-10-29 | Iniziato | William Blair | Outperform |
Mostra tutto
Guardant Health Inc Borsa (GH) Ultime notizie
Alignment Healthcare, Hims & Hers Health, Surgery Partners, Guardant Health, and Pediatrix Medical Group Stocks Trade Up, What You Need To Know - Finviz
Tumor Blood Testing Market Projections 2025-2032: Key Trends, - openPR.com
Guardant Health (GH): Buy, Sell, or Hold Post Q3 Earnings? - TradingView
Insulet, Guardant Health, agilon health, Evolent Health, and Myriad Genetics Stocks Trade Up, What You Need To Know - Yahoo Finance
Oncology Biomarker Market Accelerates Toward USD 113.5 Billion by 2034 - GlobeNewswire Inc.
Will Guardant Health Inc. (5GH) stock gain from green policiesTrend Reversal & Risk Adjusted Buy/Sell Alerts - newser.com
What risks investors should watch in Guardant Health Inc. stock2025 Price Targets & Real-Time Price Movement Reports - newser.com
Guardant Health director Tariq Musa sells $11,165 in stock By Investing.com - Investing.com Nigeria
Insider Sell Alert: Musa Tariq Sells Shares of Guardant Health I - GuruFocus
Is Guardant Health Inc. (5GH) stock in buy zone after pullbackJuly 2025 Highlights & Reliable Breakout Forecasts - newser.com
Guardant Health director Tariq Musa sells $11,165 in stock - Investing.com
Guardant Health Director Tariq Musa Sells Shares - TradingView
Dir Tariq Sells 116 ($11.2K) Of Guardant Health Inc [GH] - TradingView
Guardant Health Stock Soars with Blood Test Expansion and Strong Q3 Results - StocksToTrade
Guardant Health Stock Skyrockets After Q3 Revenue Overhaul - timothysykes.com
Sentiment analysis tools applied to Guardant Health Inc.July 2025 Action & Risk Controlled Stock Alerts - newser.com
Will Guardant Health Inc. stock recover faster than marketRecession Risk & Fast Exit/Entry Strategy Plans - newser.com
How Guardant Health Inc. (5GH) stock compares with top peersWeekly Trade Analysis & Safe Swing Trade Setups - newser.com
Relative strength of Guardant Health Inc. in sector analysisPortfolio Performance Summary & High Accuracy Buy Signal Tips - newser.com
Why Guardant Health Inc. (5GH) stock is trending on social mediaVolume Spike & AI Driven Price Forecasts - newser.com
Key metrics from Guardant Health Inc.’s quarterly dataQuarterly Trade Summary & Long-Term Capital Growth Strategies - newser.com
Dir Tariq Files To Sell 116 Of Guardant Health Inc [GH] - TradingView
Guardant Health stock reaches 52-week high at 103.4 USD By Investing.com - Investing.com Nigeria
Why Guardant Health Inc. stock is recommended by analysts2025 Price Action Summary & Reliable Entry Point Trade Alerts - newser.com
Can momentum traders help lift Guardant Health Inc.Portfolio Risk Report & Free Expert Verified Stock Movement Alerts - newser.com
How supply shortages influence Guardant Health Inc. (5GH) stockBreakout Watch & Technical Entry and Exit Tips - newser.com
Guardant Health stock reaches 52-week high at 103.4 USD - Investing.com
Is Guardant Health Inc. (5GH) stock a fit for income portfoliosJuly 2025 Trends & Stepwise Trade Signal Implementation - newser.com
Will Guardant Health Inc. stock split again soonQuarterly Portfolio Report & Breakout Confirmation Trade Signals - newser.com
Guardant Health at Jefferies: Promising Growth in Cancer Screening By Investing.com - Investing.com Canada
Can Guardant Health Inc. stock sustain institutional interest2025 Key Lessons & AI Forecasted Entry and Exit Points - newser.com
Guardant Health Stock Surges 47% In A Single Month, Wait For A Dip To Buy The Stock - Trefis
Guardant Health Inc Azioni (GH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.35%
1.41%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):